Medical Journals

Blockade of Ido Inhibits Nasal Tolerance Induction.

Authors:
  • van der Marel Arnold P J
  • Samsom Janneke N
  • Greuter Mascha
  • van Berkel Lisette A
  • O’Toole Tom
  • Kraal Georg
  • Mebius Reina E

From: Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands.

Journal of immunology (Baltimore, Md. : 1950)

  • Publish Date: Jul 2007
  • ISSN: 0022-1767
  • Volume: 179
  • Issue: 2
  • Pages: 894-900
  • Medium: Print
  • Language: English
  • Citation (JAMA): van der Marel Arnold P J, Samsom Janneke N, Greuter Mascha, et al. Blockade of Ido Inhibits Nasal Tolerance Induction.. J. Immunol. Jul 2007;179:894-900

Abstract

The amino acid tryptophan is essential for the proliferation and survival of cells. Modulation of tryptophan metabolism has been described as an important regulatory mechanism for the control of immune responses. The enzyme IDO degrades the indole moiety of tryptophan, not only depleting tryptophan but also producing immunomodulatory metabolites called kynurenines, which have apoptosis-inducing capabilities. In this study, we show that IDO is more highly expressed in nonplasmacytoid dendritic cells of the nose draining lymph nodes (LNs), which form a unique environment to induce tolerance to inhaled Ags, when compared with other peripheral LNs. Upon blockade of IDO during intranasal OVA administration, Ag-specific immune tolerance was abrogated. Analysis of Ag-specific T cells in the LNs revealed that inhibition of IDO resulted in enhanced survival at 48 h after antigenic stimulation, although this result was not mediated through alterations in apoptosis or cell proliferation. Furthermore, no differences were found in CD4(+) T cells expressing FoxP3. Our data suggest that the level of IDO expression in dendritic cells, present in nose draining LNs, allows for the generation of a sufficient number of regulatory T cells to control and balance effector T cells in such a way that immune tolerance is induced, whereas upon IDO blockade, effector T cells will outnumber regulatory T cells, leading to immunity.

Mesh Headings (Keywords): Administration, Intranasal, Adoptive Transfer, Animals, Dendritic Cells, Female, Forkhead Transcription Factors, Immune Tolerance, Indoleamine-Pyrrole 2,3,-Dioxygenase, Lymph Nodes, Mice, Mice, Inbred BALB C, Nasal Mucosa, Ovalbumin, Reverse Transcriptase Polymerase Chain Reaction, T-Lymphocytes


Check for Full Text / PubMed Unique Identifier (PMID): 17617580


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.